Grant: Collaborative Health Research Projects
University of Toronto
$177,000.00
Non-linear multimodal mircoendoscopy for lung cancer pathology
EF 2013-14
Résumé
Lung cancer is the leading cause (~28%) of cancer-related deaths. This proposal addresses two major challenges in the management of individuals at high-risk for lung cancer: A) differential diagnosis of peripheral lung lesions, and B) detection of dysplastic lesions in the central bronchus. Current technologies, such as low-dose CT and standard white-light bronchoscopy, can image dysplastic lesions but their specificity for detecting malignant tissue is very poor. Hence, there is an urgent need to classify detected lesions in situ accurately and in a minimally-invasive way. We propose to optimize, validate and integrate complementary non-linear optical techniques, including two or more of second harmonic generation (SHG), third harmonic generation (THG), coherent anti-Stokes Raman scattering (CARS) and 2-photon autofluorescence (TPF), for label-free in situ microimaging. We hypothesize that non-linear endoscopic microimaging, integrated into ultrathin scanning-fiber bronchoscopy (an emerging disruptive medical technology), will significantly increase the accuracy, and particularly the specificity, of differential diagnosis of suspicious lung lesions, including peripheral nodules, and thereby enable targeted local destruction of malignant tissue.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
414333-2012
Name nom
Barzda, Virginijus
Department département
Chemical and Physical Sciences (Mississauga)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
177000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6401
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Pathology
Research subject fr
Pathologie
Partie
2 & 3
Nb partie
3
Application title
Non-linear multimodal mircoendoscopy for lung cancer pathology
Keyword
NSERC
Application summary
Lung cancer is the leading cause (~28%) of cancer-related deaths. This proposal addresses two major challenges in the management of individuals at high-risk for lung cancer: A) differential diagnosis of peripheral lung lesions, and B) detection of dysplastic lesions in the central bronchus. Current technologies, such as low-dose CT and standard white-light bronchoscopy, can image dysplastic lesions but their specificity for detecting malignant tissue is very poor. Hence, there is an urgent need to classify detected lesions in situ accurately and in a minimally-invasive way. We propose to optimize, validate and integrate complementary non-linear optical techniques, including two or more of second harmonic generation (SHG), third harmonic generation (THG), coherent anti-Stokes Raman scattering (CARS) and 2-photon autofluorescence (TPF), for label-free in situ microimaging. We hypothesize that non-linear endoscopic microimaging, integrated into ultrathin scanning-fiber bronchoscopy (an emerging disruptive medical technology), will significantly increase the accuracy, and particularly the specificity, of differential diagnosis of suspicious lung lesions, including peripheral nodules, and thereby enable targeted local destruction of malignant tissue.